Financials United Health Products, Inc.

Equities

UEEC

US91059D1000

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 03:48:02 2024-04-26 pm EDT 5-day change 1st Jan Change
0.18 USD -1.10% Intraday chart for United Health Products, Inc. -11.07% -18.18%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 107.5 219.4 227.1 134.9 65.8 53.85
Enterprise Value (EV) 1 107.5 219.7 227.6 135.1 66.47 54.54
P/E ratio -17.8 x -32.6 x -14 x -4.36 x -38.8 x -20.1 x
Yield - - - - - -
Capitalization / Revenue 2,345 x 44,526 x 353,169 x 2,286,322 x 1,755 x -
EV / Revenue 2,344 x 44,597 x 353,968 x 2,289,665 x 1,773 x -
EV / EBITDA - - - - -23,757,245 x -22,514,742 x
EV / FCF -247 x 310 x 64.6 x 14.7 x -109 x -34.1 x
FCF Yield -0.41% 0.32% 1.55% 6.79% -0.92% -2.94%
Price to Book -307 x -242 x -238 x -118 x -31.9 x -31.4 x
Nbr of stocks (in thousands) 170,673 179,085 189,240 228,632 230,871 244,783
Reference price 2 0.6300 1.225 1.200 0.5900 0.2850 0.2200
Announcement Date 4/1/19 7/9/20 3/30/21 4/1/22 3/28/23 4/1/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.0459 0.004927 0.000643 0.000059 0.0375 -
EBITDA - - - - -2.798 -2.422
EBIT 1 -2.378 -6.094 -14.85 -29.8 -2.802 -2.427
Operating Margin -5,184.18% -123,688.09% -2,309,276.98% -50,509,550.85% -7,472.1% -
Earnings before Tax (EBT) 1 -6.006 -6.602 -15.71 -30.55 -1.688 -2.623
Net income 1 -6.006 -6.602 -15.71 -30.55 -1.688 -2.623
Net margin -13,096.1% -134,002.33% -2,443,452.57% -51,778,276.27% -4,500% -
EPS 2 -0.0353 -0.0375 -0.0855 -0.1353 -0.007345 -0.0110
Free Cash Flow 1 -0.436 0.7091 3.522 9.174 -0.6116 -1.601
FCF margin -950.7% 14,392.06% 547,669.36% 15,549,084.75% -1,630.84% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/1/19 7/9/20 3/30/21 4/1/22 3/28/23 4/1/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.35 0.51 0.2 0.67 0.69
Net Cash position 1 0.02 - - - - -
Leverage (Debt/EBITDA) - - - - -0.241 x -0.2846 x
Free Cash Flow 1 -0.44 0.71 3.52 9.17 -0.61 -1.6
ROE (net income / shareholders' equity) 1,957% 1,252% 1,692% 2,916% 105% 139%
ROA (Net income/ Total Assets) -316% -3,685% -5,976% -15,273% -928% -478%
Assets 1 1.899 0.1792 0.2629 0.2 0.1818 0.5493
Book Value Per Share 2 -0 -0.0100 -0.0100 -0 -0.0100 -0.0100
Cash Flow per Share 2 0 0 0 0 0 0
Capex - - 0.1 - - -
Capex / Sales - - 15,762.05% - - -
Announcement Date 4/1/19 7/9/20 3/30/21 4/1/22 3/28/23 4/1/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. UEEC Stock
  4. Financials United Health Products, Inc.